Overview of Endomucin in Vascular Homeostasis and Disease
Microcirculation · 2026-10 · 33 (7)
DOI: 10.1111/micc.70083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microcirculation, online erschienen am 28.08.2026. Verfasst von Rui-Fan Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microcirculation & Basic Medical College, Hebei North University, Zhangjiakou, Hebei, China. Hauptthemen laut MEDLINE: Sialomucins, Homeostasis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Innovation Capacity Training Funding Program for Master's Degree Candidates in the Hebei Province.
Abstract (Originalsprache)
Endomucin (EMCN), a highly glycosylated type I transmembrane sialomucin, is predominantly expressed on the luminal surface of venous and capillary endothelial cells and serves as a critical guardian of vascular homeostasis and immunological silencing. Its highly extended, O‐glycosylated extracellular domain provides significant steric hindrance and electrostatic repulsion, functioning as a dual physical barrier that prevents nonspecific leukocyte tethering and adhesion. Beyond its anti‐adhesive role, EMCN is a pivotal orchestrator of angiogenesis, modulating the vascular endothelial growth factor signaling cascade by facilitating vascular endothelial growth factor receptor 2 autophosphorylation at the Y1175 residue and subsequent receptor internalization. Furthermore, EMCN has emerged as a specialized marker for type H vessels and human hematopoietic stem cells, playing indispensable roles in vessel‐bone coupling and hematopoietic development. Clinical evidence indicates that the dysregulation of EMCN expression or post‐translational modifications contributes to the pathogenesis of diabetic complications, atherosclerosis, bone metabolic disorders, and tumor metastasis. This review systematically summarizes structural characteristics, expression patterns, and multifaceted biological functions of EMCN, providing a theoretical foundation for the development of novel therapeutic strategies for microvascular and metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microcirculation & Basic Medical College, Hebei North University, Zhangjiakou, Hebei, China.
- Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Zhangjiakou, Hebei, China.
- Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Shijiazhuang, Hebei, China.
- Zhangjiakou Key Laboratory of Microcirculation and Shock, Zhangjiakou, Hebei, China.
- Medical College, Zhangjiakou University, Zhangjiakou, Hebei, China.
ORCID-Profile: Rui-Fan Yang, Zhen-Ao Zhao, Zi-Gang Zhao
Förderung
- Innovation Capacity Training Funding Program for Master's Degree Candidates in the Hebei Province
Zitieren
APA
Yang, R. F., Wang, X. R., Wang, J., Du, H. B., Zhao, Z. A., & Zhao, Z. G. (2026). Overview of Endomucin in Vascular Homeostasis and Disease. Microcirculation, 33(7). https://doi.org/10.1111/micc.70083
Vancouver
Yang RF, Wang XR, Wang J, Du HB, Zhao ZA, Zhao ZG. Overview of Endomucin in Vascular Homeostasis and Disease. Microcirculation. 2026;33(7). doi:10.1111/micc.70083
BibTeX
@article{Yang2026,
author = {Yang, Rui-Fan and Wang, Xiao-Rong and Wang, Jing and Du, Hui-Bo and Zhao, Zhen-Ao and Zhao, Zi-Gang},
title = {Overview of Endomucin in Vascular Homeostasis and Disease},
journal = {Microcirculation},
year = {2026},
volume = {33},
number = {7},
doi = {10.1111/micc.70083}
}
EUVIMED